Beyond its role in EndMT, GDF15 promotes AKT phosphorylation in a TGFBR2-dependent manner, hence increasing the resistance of esophageal squamous cell carcinoma cells to low-dose cisplatin [50]. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.